Related Experiment Video

Updated: Jul 19, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

Cellular senescence and cancer treatment

Clemens A Schmitt1

  • 1Department of Internal Medicine/Hematology and Oncology, Charité-Universitätsmedizin Berlin (CVK), Augustenburger Platz 1, Berlin, Germany. clemens.schmitt@charite.de

Biochimica Et Biophysica Acta
|October 10, 2006
PubMed

Insights

Cellular senescence, a cell-cycle arrest, acts as a tumor suppressor by halting premalignant growth and enhancing chemotherapy response. This review explores its pathways and clinical impact.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Cellular senescence is an irreversible cell-cycle arrest triggered by stress.
  • It functions as a protective mechanism against uncontrolled cell proliferation.
  • Recent research highlights its role in tumor suppression and cancer treatment.

Purpose of the Study:

  • To review the molecular pathways of stress-induced senescence.
  • To discuss the impact of senescence on clinical outcomes.
  • To examine the interplay between senescence and apoptosis in cancer therapy.

Main Methods:

  • Literature review of recent studies on cellular senescence.
  • Analysis of molecular pathways involved in stress-induced senescence.
  • Discussion of clinical implications and therapeutic relevance.

Main Results:

  • Cellular senescence acts as a natural barrier against oncogenic activation, preventing tumorigenesis.
  • Senescence is a key response to DNA-damaging chemotherapeutic agents.
  • Premature senescence and apoptosis share critical overlaps as tumor-suppressive and drug-responsive programs.

Conclusions:

  • Cellular senescence is a vital tumor suppressor mechanism.
  • Senescence plays a critical role in the efficacy of chemotherapy.
  • Understanding senescence pathways offers therapeutic opportunities in oncology.

More Related Videos

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

Techniques to Induce and Quantify Cellular Senescence06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...